| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |